Takeda Pharmaceuticals America
UEI: ENNFDLWFC6L1
• CAGE: 3FLV7
Overview
Awardee Type
Parent
Company Description
Discover Takeda Oncology's decades of leadership in oncology. Explore their approach, latest news, pipeline, and innovative therapies.
Name
Takeda Pharmaceuticals America
Website
Headquarters
Cambridge, MA
United States
United States
Most Recent Award
April 10, 2025
Calculating
Federal contract recipient
TAKEDA PHARMACEUTICALS AMERICA, INC.
(UEI ENNFDLWFC6L1, CAGE 3FLV7)
is headquartered in Cambridge MA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 1993 and
federally registered in
May 2003.
Federal Award Analysis
Takeda Pharmaceuticals America federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
TAKEDA PHARMACEUTICALS AMERICA, INC.
UEI
ENNFDLWFC6L1
CAGE Code
3FLV7
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 13, 1993
Initial Registration
May 22, 2003
Last Registration
April 1, 2025
Registration Activation
Oct. 21, 2024
Registration Expiration
Oct. 17, 2025
Fiscal Year End
March 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Takeda Pharmaceuticals America
GSA Schedules and Price Lists
- Takeda Pharmaceuticals America
- PoP: 9/29/18 - 8/31/25
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $4,492,025